Leigh, Steven; Thompson, Caroline Mary; Leigh, Mathew Louis Steven;

Membrane lipid compositions

A composition in the form of a dry powder and which comprises: a) at least one membrane lipid, and b) at least one biologically active compound comprising a xanthine and/or a carboxylic acid, and which forms structured lipid assemblies when dispersed/dissolved in an aqueous medium. A method of preparing such a composition is also provided, together with a dispersion of structured lipid assemblies suspended in a solution of at least one biologically active compound and a method of preparing the same. The compositions and dispersions are suitable for use in creams and lotions for skin care.

• Governor stabilizer Disc cartridge
• Training aid for skating Reconfigurable clamp
• Power tool apparatus Process
• Microdisplay with eye gaze detection Door extension for vehicle doors
• Low thermal inertia heater Golf ball setting apparatus
• Fish scaler apparatus Bale handling apparatus
• Damped elastic stop device Multiple sensor electronic assembly
• Roasting appliance Illuminated automotive emblem
• Ion sensitive combination electrode Joint protector pad
• Turbine water atomizer Portable ventilation system
• Electrophotographic process for multiple images Threshing apparatus
• Discharge lamp lighting circuit Educational doll
• Flow controllers for powder lacquers Image projector
• Fluid dispenser with fill adapter Ignition spark enhancing device
• Production of isocyanic acid Household grist mill
• Psychological testing apparatus Bathtub cushion lift stabilization
• Position adjustable battery adapter Bandage elevation device
• Selectively operable rotary drive means Signal strength detecting circuit
• Blade sealing for impeller pumps Reusable wall fastener
• In-line roller skate Turntable transfer mechanism for conveyors
• Portable liquid dispenser Copolyamide containing tertiary amine linkage
• Multi-capillary electrophoresis apparatus External ligament system
• Idler roll bearing assembly Moving coil type instrument
• Linerless bottle cap Satellite having a stackable configuration
• Paint spray booth Differential rate screening
• Digital micromirror stage lighting system Composition for gastrointestinal ulcers

1. A composition in the form of a homogenous dry powder mixture wherein the mean particle size of the powder composition is between 0.1 to 5 mm in diameter consisting essentially of:

a) at least one membrane lipid in an amount of from 5% to 70% by weight,

b) at least one biologically active compound that is a carboxylic acid selected from the group consisting of an α-hydroxycarboxylic acid, a β-hydroxycarboxylic acid and/or an α-ketocarboxylic acid, and

c) at least one biologically active compound that is a xanthine selected from the group consisting of caffeine, aminophilline, theophylline and theobromine,

and which is prepared by mixing or milling together said components to obtain the dry powder mixture,

and which forms structured lipid assemblies when dispersed/dissolved in an aqueous medium.

2. The composition as claimed in claim 1, wherein said membrane lipid comprises a phospholipid or mixture of phospholipids.

3. The composition as claimed in claim 1, wherein said biologically active compound is salicylic acid or a pharmaceutically acceptable salt thereof in an amount of from 10% to 50% by weight.

4. The composition as claimed in claim 1, wherein the xanthine is caffeine and is present in an amount of from 10% to 80% by weight.

5. The composition as claimed in claim 1, wherein the proportion of said membrane lipid to said biologically active compounds is from 1:20 to 20:1 by weight.

6. A method of preparing a composition in the form of a homogenous dry powder mixture the mean particle size of the composition being between 0.1 to 5 mm and which composition consisting essentially of:

a) at least one membrane lipid in an amount of from 5% to 70% by weight, b) at least one biologically active compound that is a carboxylic acid selected from the group consisting of an α-hydroxycarboxylic acid, a β-hydroxycarboxylic acid and/or an α-ketocarboxylic acid, and

c) at least one biologically active compound that is a xanthine selected from the group consisting of caffeine, aminophilline, theophylline and theobromine, and which forms structured lipid assemblies when dispersed/dissolved in an aqueous medium, which method comprises mixing or milling together the components to produce a homogeneous dry powder mixture.

7. A composition in the form of a homogeneous dry powder mixture which is prepared according to the method of claim 6.

8. The composition as claimed in claim 1, wherein the xanthine is caffeine.